308 related articles for article (PubMed ID: 25574751)
1. Case report of an adolescent girl with limb-girdle muscular dystrophy type 2B - the usefulness of muscle protein immunostaining in the diagnosis of dysferlinopathies.
Szymanska S; Rokicki D; Karkucinska-Wieckowska A; Szymanska-Debinska T; Ciara E; Ploski R; Grajkowska W; Pronicki M
Folia Neuropathol; 2014; 52(4):452-6. PubMed ID: 25574751
[TBL] [Abstract][Full Text] [Related]
2. DYSF mutation analysis in a group of Chinese patients with dysferlinopathy.
Zhao Z; Hu J; Sakiyama Y; Okamoto Y; Higuchi I; Li N; Shen H; Takashima H
Clin Neurol Neurosurg; 2013 Aug; 115(8):1234-7. PubMed ID: 23254335
[TBL] [Abstract][Full Text] [Related]
3. Pattern of skeletal muscle involvement in primary dysferlinopathies: a whole-body 3.0-T magnetic resonance imaging study.
Kesper K; Kornblum C; Reimann J; Lutterbey G; Schröder R; Wattjes MP
Acta Neurol Scand; 2009 Aug; 120(2):111-8. PubMed ID: 19154541
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous characteristics of Korean patients with dysferlinopathy.
Park HJ; Hong JM; Suh GI; Shin HY; Kim SM; Sunwoo IN; Suh BC; Choi YC
J Korean Med Sci; 2012 Apr; 27(4):423-9. PubMed ID: 22468107
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes.
Nguyen K; Bassez G; Krahn M; Bernard R; Laforêt P; Labelle V; Urtizberea JA; Figarella-Branger D; Romero N; Attarian S; Leturcq F; Pouget J; Lévy N; Eymard B
Arch Neurol; 2007 Aug; 64(8):1176-82. PubMed ID: 17698709
[TBL] [Abstract][Full Text] [Related]
6. Painful enlargement of the calf muscles in limb girdle muscular dystrophy type 2B (LGMD2B) with a novel compound heterozygous mutation in DYSF.
Diers A; Carl M; Stoltenburg-Didinger G; Vorgerd M; Spuler S
Neuromuscul Disord; 2007 Feb; 17(2):157-62. PubMed ID: 17129727
[TBL] [Abstract][Full Text] [Related]
7. Proteasomal inhibition restores biological function of mis-sense mutated dysferlin in patient-derived muscle cells.
Azakir BA; Di Fulvio S; Kinter J; Sinnreich M
J Biol Chem; 2012 Mar; 287(13):10344-10354. PubMed ID: 22318734
[TBL] [Abstract][Full Text] [Related]
8. Full-length dysferlin expression driven by engineered human dystrophic blood derived CD133+ stem cells.
Meregalli M; Navarro C; Sitzia C; Farini A; Montani E; Wein N; Razini P; Beley C; Cassinelli L; Parolini D; Belicchi M; Parazzoli D; Garcia L; Torrente Y
FEBS J; 2013 Dec; 280(23):6045-60. PubMed ID: 24028392
[TBL] [Abstract][Full Text] [Related]
9. Dysferlinopathies: Clinical and genetic variability.
Ivanova A; Smirnikhina S; Lavrov A
Clin Genet; 2022 Dec; 102(6):465-473. PubMed ID: 36029111
[TBL] [Abstract][Full Text] [Related]
10. Lipid accumulation in dysferlin-deficient muscles.
Grounds MD; Terrill JR; Radley-Crabb HG; Robertson T; Papadimitriou J; Spuler S; Shavlakadze T
Am J Pathol; 2014 Jun; 184(6):1668-76. PubMed ID: 24685690
[TBL] [Abstract][Full Text] [Related]
11. Limb-Girdle Muscular Dystrophy 2B and Miyoshi Presentations of Dysferlinopathy.
Patel NJ; Van Dyke KW; Espinoza LR
Am J Med Sci; 2017 May; 353(5):484-491. PubMed ID: 28502335
[TBL] [Abstract][Full Text] [Related]
12. Dysferlinopathy: a clinical and histopathological study of 28 patients from India.
Nalini A; Gayathri N
Neurol India; 2008; 56(3):379-85; discussion 386-7. PubMed ID: 18974568
[TBL] [Abstract][Full Text] [Related]
13. Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s).
Weiler T; Bashir R; Anderson LV; Davison K; Moss JA; Britton S; Nylen E; Keers S; Vafiadaki E; Greenberg CR; Bushby CR; Wrogemann K
Hum Mol Genet; 1999 May; 8(5):871-7. PubMed ID: 10196377
[TBL] [Abstract][Full Text] [Related]
14. [Amyloidosis in muscular dystrophy].
Carl M; Röcken C; Spuler S
Pathologe; 2009 May; 30(3):235-9. PubMed ID: 19326120
[TBL] [Abstract][Full Text] [Related]
15. Comparison of dysferlin expression in human skeletal muscle with that in monocytes for the diagnosis of dysferlin myopathy.
Gallardo E; de Luna N; Diaz-Manera J; Rojas-García R; Gonzalez-Quereda L; Flix B; de Morrée A; van der Maarel S; Illa I
PLoS One; 2011; 6(12):e29061. PubMed ID: 22194990
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B.
Takahashi T; Aoki M; Suzuki N; Tateyama M; Yaginuma C; Sato H; Hayasaka M; Sugawara H; Ito M; Abe-Kondo E; Shimakura N; Ibi T; Kuru S; Wakayama T; Sobue G; Fujii N; Saito T; Matsumura T; Funakawa I; Mukai E; Kawanami T; Morita M; Yamazaki M; Hasegawa T; Shimizu J; Tsuji S; Kuzuhara S; Tanaka H; Yoshioka M; Konno H; Onodera H; Itoyama Y
J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):433-40. PubMed ID: 23243261
[TBL] [Abstract][Full Text] [Related]
17. Limb Girdle Muscular Dystrophy Type 2B (LGMD2B): Diagnosis and Therapeutic Possibilities.
Poudel BH; Fletcher S; Wilton SD; Aung-Htut M
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891760
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic features and genetic findings in 2 chinese families with Miyoshi distal myopathy.
Ro LS; Lee-Chen GJ; Lin TC; Wu YR; Chen CM; Lin CY; Chen ST
Arch Neurol; 2004 Oct; 61(10):1594-9. PubMed ID: 15477515
[TBL] [Abstract][Full Text] [Related]
19. Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies.
Paradas C; Llauger J; Diaz-Manera J; Rojas-García R; De Luna N; Iturriaga C; Márquez C; Usón M; Hankiewicz K; Gallardo E; Illa I
Neurology; 2010 Jul; 75(4):316-23. PubMed ID: 20574037
[TBL] [Abstract][Full Text] [Related]
20. Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.
Flix B; de la Torre C; Castillo J; Casal C; Illa I; Gallardo E
Int J Biochem Cell Biol; 2013 Aug; 45(8):1927-38. PubMed ID: 23792176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
